Blue light cystoscopy is tied to higher resource use, not health care cost, in NMIBCByHannah ClarkeAugust 11th 2026
The UroOnc Minute: Navigating BCG Maintenance Therapy in NMIBC, With Mark D. Tyson, II, MD, MPHByAdam B. Weiner, MD,Mark D. Tyson, MD, MPHAugust 7th 2026
Trial to evaluate ivonescimab plus enfortumab vedotin in urothelial carcinomaByHannah ClarkeAugust 5th 2026
Laura Bukavina, MD, and Gabriela Díaz, MD, on the rise of young-onset bladder cancerByLaura Bukavina, MD, MPH, MSc,Gabriela M. Diáz, MDAugust 3rd 2026